Opiate Use and Biliary Dilation
Status unconfirmed
Conditions studied: Evaluation of Association Between Opiate Use and Biliary Dilation
In brief
We hope to better define the association between opiate use and biliary dilation, which was evident in our previous retrospective study. This prospective study including all endoscopic ultrasound procedures performed for further evaluation of biliary dilatation in the setting of bilirubin \<2 mg/dL will enable accurate measurement of common bile duct and pancreatic duct diameter using endoscopic ultrasound and identification of other non- obstructive factors which may modulate biliary dilation (i.e. age, cholecystectomy status, duration and type of opiate used).
Key facts
- Study ID
- NCT03870347
- Run by
- Stanford University
- People needed
- 100
- Starts
- 2018-01-03
- Expected to finish
- 2022-01-01
- Last updated by the study team
- 2019-03-12
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Referral/consultation for consideration for EUS ± ERCP
- Age 18 and older
- Evidence of biliary dilation on abdominal imaging without obstructive pattern on liver function tests or imaging.
- Willing and able to comply with the study procedures and provide written informed consent to participate in the study.
You may not qualify if…
- Age <18
- Potentially vulnerable subjects including, homeless people, pregnant females, employees and students.
- Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit
- Other biliary process which accounts for patient's abnormal liver function studies/imaging (i.e. mass, stone, cirrhosis).
Where it is running
- Stanford University Medical Center — Stanford, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.